Biogen
BIIB
#1088
Rank
$18.70 B
Marketcap
$127.62
Share price
0.84%
Change (1 day)
-43.64%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) Fails to deliver data

Key failure to deliver metrics for Biogen:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Biogen (BIIB) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Biogen (BIIB) - since 2013

Volume in USD (price x number of shares), data since 2013

Biogen (BIIB) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025$28.93 M-59.75%
2024$71.88 M27.44%
2023$56.4 M-14.65%
2022$66.08 M7.92%
2021$61.24 M-56.04%
2020$0.13 B67.82%
2019$83.01 M-43.79%
2018$0.14 B69.32%
2017$87.22 M-29.4%
2016$0.12 B-16.47%
2015$0.14 B-18.15%
2014$0.18 B579.65%
2013$26.59 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Amgen
AMGN
$82.72 M$0.33 B๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$0.16 B$0.25 B๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$33.49 M$0.23 B๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$28.79 M$0.35 B๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$8.74 M$0.19 B๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
N/A$0.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$28.15 M$43.66 M๐Ÿ‡ซ๐Ÿ‡ท France
Bio-Rad Laboratories
BIO
$3.09 M$17.23 M๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$3.85 M$72.94 M๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
$2.71 M$4.94 M๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands